[Gilteritinib for pediatric FLT3 internal tandem duplication-positive recurrent acute myeloid leukemia].
Fukuoka K, Tsumura Y, Noguchi J, Sugawa M, Takaki T, Hiraki T, Inoue K, Mitani Y, Tomita O, Oshima K, Yanagi M, Isobe K, Mori M, Arakawa Y, Koh K.
Fukuoka K, et al. Among authors: mori m.
Rinsho Ketsueki. 2020;61(4):322-326. doi: 10.11406/rinketsu.61.322.
Rinsho Ketsueki. 2020.
PMID: 32378574
Japanese.